APO Research
Talk to an analyst

APO RESEARCH · REPORT

Breast Tissue Markers

Breast tissue markers are small, permanently implantable medical devices that are placed into the breast at the time of image-guided biopsy or surgery to mark the exact location of a lesion, biopsy site, or surgical cavity for future identification and treatment planning. They are typically composed of biocompatible, radiopaque materials such as titanium, stainless steel, nitinol, or specially formulated polymers, sometimes combined with bioresorbable carrier matrices, and are designed to be clearly visible on mammography, ultrasound, and/or MRI while producing minimal imaging artifacts. Delivered through a dedicated introducer needle or applicator under stereotactic, ultrasound, or MRI guidance, the marker remains in situ indefinitely, providing a durable reference point that enables radiologists and surgeons to relocate small or completely excised lesions, correlate findings across different imaging modalities, guide re-biopsy or lumpectomy, and support accurate radiation therapy targeting. As an implantable device used in the breast, a breast tissue marker must meet stringent standards for biocompatibility, mechanical stability, and positional integrity over time, while maintaining patient comfort and not interfering with subsequent diagnostic procedures or treatments.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Breast tissue markers are small, permanently implantable medical devices that are placed into the breast at the time of image-guided biopsy or surgery to mark the exact location of a lesion, biopsy site, or surgical cavity for future identification and treatment planning. They are typically composed of biocompatible, radiopaque materials such as titanium, stainless steel, nitinol, or specially formulated polymers, sometimes combined with bioresorbable carrier matrices, and are designed to be clearly visible on mammography, ultrasound, and/or MRI while producing minimal imaging artifacts. Delivered through a dedicated introducer needle or applicator under stereotactic, ultrasound, or MRI guidance, the marker remains in situ indefinitely, providing a durable reference point that enables radiologists and surgeons to relocate small or completely excised lesions, correlate findings across different imaging modalities, guide re-biopsy or lumpectomy, and support accurate radiation therapy targeting. As an implantable device used in the breast, a breast tissue marker must meet stringent standards for biocompatibility, mechanical stability, and positional integrity over time, while maintaining patient comfort and not interfering with subsequent diagnostic procedures or treatments.

Selected research

Industry Growth & Trends

Global Breast Tissue Markers Industry Growth and Trends Forecast to 2032

28 December 202595 pages

Choose your research edition.

Industry ResearchBreast Tissue Markers Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Breast Tissue Markers Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Breast Tissue Markers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Breast Tissue Markers Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Breast Tissue Markers Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Breast tissue markers are small, permanently implantable medical devices that are placed into the breast at the time of image-guided biopsy or surgery to mark the exact location of a lesion, biopsy site, or surgical cavity for future identification and treatment planning. They are typically composed of biocompatible, radiopaque materials such as titanium, stainless steel, nitinol, or specially formulated polymers, sometimes combined with bioresorbable carrier matrices, and are designed to be clearly visible on mammography, ultrasound, and/or MRI while producing minimal imaging artifacts. Delivered through a dedicated introducer needle or applicator under stereotactic, ultrasound, or MRI guidance, the marker remains in situ indefinitely, providing a durable reference point that enables radiologists and surgeons to relocate small or completely excised lesions, correlate findings across different imaging modalities, guide re-biopsy or lumpectomy, and support accurate radiation therapy targeting. As an implantable device used in the breast, a breast tissue marker must meet stringent standards for biocompatibility, mechanical stability, and positional integrity over time, while maintaining patient comfort and not interfering with subsequent diagnostic procedures or treatments.

The global Breast Tissue Markers market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Breast Tissue Markers is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

Read the full market overview

The Europe market for Breast Tissue Markers is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

The Asia Pacific market for Breast Tissue Markers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Breast Tissue Markers include Hologic, Somatex Medical, Mermaid Medical, Mammotome, BD, Argon Medical, Carbon Medical Technologies and INRAD, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Breast Tissue Markers market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Breast Tissue Markers market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Breast Tissue Markers market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Breast Tissue Markers.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Breast Tissue Markers market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Breast Tissue Markers Market by Company

Hologic

Somatex Medical

Mermaid Medical

Mammotome

BD

Argon Medical

Carbon Medical Technologies

INRAD

Breast Tissue Markers Segment by Type

CA125

CA15-3

CEA

CA27-29

Others

Breast Tissue Markers Segment by Application

Clinic

Hospital

Ambulatory Surgery Centers (ASCs)

Breast Tissue Markers Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Breast Tissue Markers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Breast Tissue Markers and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Breast Tissue Markers.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Breast Tissue Markers manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Breast Tissue Markers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of CA125 Table 2. Major Company of CA15-3 Table 3. Major Company of CEA Table 4. Major Company of CA27-29 Table 5. Major Company of Others Table 6. Global Breast Tissue Markers Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Breast Tissue Markers Sales by Type (2021-2026) & (k units) Table 8. Global Breast Tissue Markers Sales Market Share in Volume by Type (2021-2026) Table 9. Global Breast Tissue Markers Sales by Type (2021-2026) & (US$ Million) Table 10. Global Breast Tissue Markers Sales Market Share in Value by Type (2021-2026) Table 11. Global Breast Tissue Markers Price by Type (2021-2026) & (USD/unit) Table 12. Global Breast Tissue Markers Sales by Type (2027-2032) & (k units) Table 13. Global Breast Tissue Markers Sales Market Share in Volume by Type (2027-2032) Table 14. Global Breast Tissue Markers Sales by Type (2027-2032) & (US$ Million) Table 15. Global Breast Tissue Markers Sales Market Share in Value by Type (2027-2032) Table 16. Global Breast Tissue Markers Price by Type (2027-2032) & (USD/unit) Table 17. North America Breast Tissue Markers Sales by Type (2021-2026) & (k units) Table 18. North America Breast Tissue Markers Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Breast Tissue Markers Sales by Type (2021-2026) & (k units) Table 20. Europe Breast Tissue Markers Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Breast Tissue Markers Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Breast Tissue Markers Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Breast Tissue Markers Sales by Type (2021-2026) & (k units) Table 24. Latin America Breast Tissue Markers Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Breast Tissue Markers Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Breast Tissue Markers Sales by Type (2021-2026) & (US$ Million) Table 27. Breast Tissue Markers Industry Trends Table 28. Breast Tissue Markers Industry Drivers Table 29. Breast Tissue Markers Industry Opportunities and Challenges Table 30. Breast Tissue Markers Industry Restraints Table 31. Global Breast Tissue Markers Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Breast Tissue Markers Revenue Market Share by Company (2021-2026) Table 33. Global Breast Tissue Markers Sales by Company (2021-2026) & (k units) Table 34. Global Breast Tissue Markers Sales Share by Company (2021-2026) Table 35. Global Breast Tissue Markers Market Price by Company (2021-2026) & (USD/unit) Table 36. Global Breast Tissue Markers Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Breast Tissue Markers Major Company Production Sites and Headquarters Table 38. Global Breast Tissue Markers Company, Product Type & Application Table 39. Global Breast Tissue Markers Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Breast Tissue Markers by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Breast Tissue Markers Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Breast Tissue Markers Sales by Region (2021-2026) & (k units) Table 44. Global Breast Tissue Markers Sales Market Share in Volume by Region (2021-2026) Table 45. Global Breast Tissue Markers Sales by Region (2021-2026) & (US$ Million) Table 46. Global Breast Tissue Markers Sales Market Share in Value by Region (2021-2026) Table 47. Global Breast Tissue Markers Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 48. Global Breast Tissue Markers Sales by Region (2027-2032) & (k units) Table 49. Global Breast Tissue Markers Sales Market Share in Volume by Region (2027-2032) Table 50. Global Breast Tissue Markers Sales by Region (2027-2032) & (US$ Million) Table 51. Global Breast Tissue Markers Sales Market Share in Value by Region (2027-2032) Table 52. Global Breast Tissue Markers Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 53. Global Breast Tissue Markers Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Breast Tissue Markers Sales by Application (2021-2026) & (k units) Table 55. Global Breast Tissue Markers Sales Market Share in Volume by Application (2021-2026) Table 56. Global Breast Tissue Markers Sales by Application (2021-2026) & (US$ Million) Table 57. Global Breast Tissue Markers Sales Market Share in Value by Application (2021-2026) Table 58. Global Breast Tissue Markers Price by Application (2021-2026) & (USD/unit) Table 59. Global Breast Tissue Markers Sales by Application (2027-2032) & (k units) Table 60. Global Breast Tissue Markers Sales Market Share in Volume by Application (2027-2032) Table 61. Global Breast Tissue Markers Sales by Application (2027-2032) & (US$ Million) Table 62. Global Breast Tissue Markers Sales Market Share in Value by Application (2027-2032) Table 63. Global Breast Tissue Markers Price by Application (2027-2032) & (USD/unit) Table 64. North America Breast Tissue Markers Sales by Application (2021-2026) & (k units) Table 65. North America Breast Tissue Markers Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Breast Tissue Markers Sales by Application (2021-2026) & (k units) Table 67. Europe Breast Tissue Markers Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Breast Tissue Markers Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Breast Tissue Markers Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Breast Tissue Markers Sales by Application (2021-2026) & (k units) Table 71. Latin America Breast Tissue Markers Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Breast Tissue Markers Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Breast Tissue Markers Sales by Application (2021-2026) & (US$ Million) Table 74. Hologic Company Information Table 75. Hologic Business Overview Table 76. Hologic Breast Tissue Markers Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. Hologic Breast Tissue Markers Product Portfolio Table 78. Hologic Recent Development Table 79. Somatex Medical Company Information Table 80. Somatex Medical Business Overview Table 81. Somatex Medical Breast Tissue Markers Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. Somatex Medical Breast Tissue Markers Product Portfolio Table 83. Somatex Medical Recent Development Table 84. Mermaid Medical Company Information Table 85. Mermaid Medical Business Overview Table 86. Mermaid Medical Breast Tissue Markers Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Mermaid Medical Breast Tissue Markers Product Portfolio Table 88. Mermaid Medical Recent Development Table 89. Mammotome Company Information Table 90. Mammotome Business Overview Table 91. Mammotome Breast Tissue Markers Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Mammotome Breast Tissue Markers Product Portfolio Table 93. Mammotome Recent Development Table 94. BD Company Information Table 95. BD Business Overview Table 96. BD Breast Tissue Markers Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. BD Breast Tissue Markers Product Portfolio Table 98. BD Recent Development Table 99. Argon Medical Company Information Table 100. Argon Medical Business Overview Table 101. Argon Medical Breast Tissue Markers Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Argon Medical Breast Tissue Markers Product Portfolio Table 103. Argon Medical Recent Development Table 104. Carbon Medical Technologies Company Information Table 105. Carbon Medical Technologies Business Overview Table 106. Carbon Medical Technologies Breast Tissue Markers Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Carbon Medical Technologies Breast Tissue Markers Product Portfolio Table 108. Carbon Medical Technologies Recent Development Table 109. INRAD Company Information Table 110. INRAD Business Overview Table 111. INRAD Breast Tissue Markers Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. INRAD Breast Tissue Markers Product Portfolio Table 113. INRAD Recent Development Table 114. North America Breast Tissue Markers Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 115. North America Breast Tissue Markers Sales by Country (2021-2026) & (k units) Table 116. North America Breast Tissue Markers Sales Market Share by Country (2021-2026) Table 117. North America Breast Tissue Markers Sales Forecast by Country (2027-2032) & (k units) Table 118. North America Breast Tissue Markers Sales Market Share Forecast by Country (2027-2032) Table 119. North America Breast Tissue Markers Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. North America Breast Tissue Markers Market Size by Country (2021-2026) & (US$ Million) Table 121. North America Breast Tissue Markers Market Share by Country (2021-2026) Table 122. North America Breast Tissue Markers Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. North America Breast Tissue Markers Market Share Forecast by Country (2027-2032) Table 124. Europe Breast Tissue Markers Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 125. Europe Breast Tissue Markers Sales by Country (2021-2026) & (k units) Table 126. Europe Breast Tissue Markers Sales Market Share by Country (2021-2026) Table 127. Europe Breast Tissue Markers Sales Forecast by Country (2027-2032) & (k units) Table 128. Europe Breast Tissue Markers Sales Market Share Forecast by Country (2027-2032) Table 129. Europe Breast Tissue Markers Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Europe Breast Tissue Markers Market Size by Country (2021-2026) & (US$ Million) Table 131. Europe Breast Tissue Markers Market Share by Country (2021-2026) Table 132. Europe Breast Tissue Markers Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Europe Breast Tissue Markers Market Share Forecast by Country (2027-2032) Table 134. Asia-Pacific Breast Tissue Markers Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 135. Asia-Pacific Breast Tissue Markers Sales by Country (2021-2026) & (k units) Table 136. Asia-Pacific Breast Tissue Markers Sales Market Share by Country (2021-2026) Table 137. Asia-Pacific Breast Tissue Markers Sales Forecast by Country (2027-2032) & (k units) Table 138. Asia-Pacific Breast Tissue Markers Sales Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Breast Tissue Markers Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Breast Tissue Markers Market Size by Country (2021-2026) & (US$ Million) Table 141. Asia-Pacific Breast Tissue Markers Market Share by Country (2021-2026) Table 142. Asia-Pacific Breast Tissue Markers Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Asia-Pacific Breast Tissue Markers Market Share Forecast by Country (2027-2032) Table 144. Latin America Breast Tissue Markers Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 145. Latin America Breast Tissue Markers Sales by Country (2021-2026) & (k units) Table 146. Latin America Breast Tissue Markers Sales Market Share by Country (2021-2026) Table 147. Latin America Breast Tissue Markers Sales Forecast by Country (2027-2032) & (k units) Table 148. Latin America Breast Tissue Markers Sales Market Share Forecast by Country (2027-2032) Table 149. Latin America Breast Tissue Markers Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Latin America Breast Tissue Markers Market Size by Country (2021-2026) & (US$ Million) Table 151. Latin America Breast Tissue Markers Market Share by Country (2021-2026) Table 152. Latin America Breast Tissue Markers Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Latin America Breast Tissue Markers Market Share Forecast by Country (2027-2032) Table 154. Middle East and Africa Breast Tissue Markers Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 155. Middle East and Africa Breast Tissue Markers Sales by Country (2021-2026) & (k units) Table 156. Middle East and Africa Breast Tissue Markers Sales Market Share by Country (2021-2026) Table 157. Middle East and Africa Breast Tissue Markers Sales Forecast by Country (2027-2032) & (k units) Table 158. Middle East and Africa Breast Tissue Markers Sales Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Breast Tissue Markers Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Breast Tissue Markers Market Size by Country (2021-2026) & (US$ Million) Table 161. Middle East and Africa Breast Tissue Markers Market Share by Country (2021-2026) Table 162. Middle East and Africa Breast Tissue Markers Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Middle East and Africa Breast Tissue Markers Market Share Forecast by Country (2027-2032) Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Breast Tissue Markers Distributors List Table 167. Breast Tissue Markers Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Breast Tissue Markers Image Figure 2. Global Breast Tissue Markers Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Breast Tissue Markers Market Size (2021-2032) & (US$ Million) Figure 4. Global Breast Tissue Markers Sales (2021-2032) & (k units) Figure 5. CA125 Image Figure 6. Global CA125 Sales YoY Growth (2021-2032) & (k units) Figure 7. CA15-3 Image Figure 8. Global CA15-3 Sales YoY Growth (2021-2032) & (k units) Figure 9. CEA Image Figure 10. Global CEA Sales YoY Growth (2021-2032) & (k units) Figure 11. CA27-29 Image Figure 12. Global CA27-29 Sales YoY Growth (2021-2032) & (k units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Breast Tissue Markers Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Breast Tissue Markers Market Share by Type 2025 VS 2032 Figure 17. North America Breast Tissue Markers Sales Market Share in Volume by Type in 2025 Figure 18. North America Breast Tissue Markers Sales Market Share in Value by Type in 2025 Figure 19. Europe Breast Tissue Markers Sales Market Share in Volume by Type in 2025 Figure 20. Europe Breast Tissue Markers Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Breast Tissue Markers Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Breast Tissue Markers Sales Market Share in Value by Type in 2025 Figure 23. Latin America Breast Tissue Markers Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Breast Tissue Markers Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Breast Tissue Markers Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Breast Tissue Markers Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Breast Tissue Markers Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 31. Hospital Image Figure 32. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 33. Ambulatory Surgery Centers (ASCs) Image Figure 34. Global Ambulatory Surgery Centers (ASCs) Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Breast Tissue Markers Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Breast Tissue Markers Market Share by Application 2025 VS 2032 Figure 37. North America Breast Tissue Markers Sales Market Share in Volume by Application in 2025 Figure 38. North America Breast Tissue Markers Sales Market Share in Value by Application in 2025 Figure 39. Europe Breast Tissue Markers Sales Market Share in Volume by Application in 2025 Figure 40. Europe Breast Tissue Markers Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Breast Tissue Markers Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Breast Tissue Markers Sales Market Share in Value by Application in 2025 Figure 43. Latin America Breast Tissue Markers Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Breast Tissue Markers Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Breast Tissue Markers Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Breast Tissue Markers Sales Market Share in Value by Application in 2025 Figure 47. North America Breast Tissue Markers Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Breast Tissue Markers Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Breast Tissue Markers Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Breast Tissue Markers Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Breast Tissue Markers Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Breast Tissue Markers Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Breast Tissue Markers Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Breast Tissue Markers Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Breast Tissue Markers Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Breast Tissue Markers Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Breast Tissue Markers Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Breast Tissue Markers Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Breast Tissue Markers Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Breast Tissue Markers Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Breast Tissue Markers Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Breast Tissue Markers Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Breast Tissue Markers Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Breast Tissue Markers Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Breast Tissue Markers Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Breast Tissue Markers Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Breast Tissue Markers Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Breast Tissue Markers Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • CA125
  • CA15-3
  • CEA
  • CA27-29
  • Others
Applications
  • Clinic
  • Hospital
  • Ambulatory Surgery Centers (ASCs)
Companies covered
  • Hologic
  • Somatex Medical
  • Mermaid Medical
  • Mammotome
  • BD
  • Argon Medical
  • Carbon Medical Technologies
  • INRAD

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Breast Tissue Markers Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Breast Tissue Markers Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Breast Tissue Markers Market by Type
  6. 1.3.1 CA125
  7. 1.3.2 CA15-3
  8. 1.3.3 CEA
  9. 1.3.4 CA27-29
  10. 1.3.5 Others
  11. 1.4 Global Breast Tissue Markers Market Size by Type
  12. 1.4.1 Global Breast Tissue Markers Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Breast Tissue Markers Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Breast Tissue Markers Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Breast Tissue Markers Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Breast Tissue Markers Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Breast Tissue Markers Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Breast Tissue Markers Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Breast Tissue Markers Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Breast Tissue Markers Industry Trends
  2. 2.2 Breast Tissue Markers Industry Drivers
  3. 2.3 Breast Tissue Markers Industry Opportunities and Challenges
  4. 2.4 Breast Tissue Markers Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Breast Tissue Markers Revenue (2021-2026)
  2. 3.2 Global Top Players by Breast Tissue Markers Sales (2021-2026)
  3. 3.3 Global Top Players by Breast Tissue Markers Price (2021-2026)
  4. 3.4 Global Breast Tissue Markers Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Breast Tissue Markers Major Company Production Sites & Headquarters
  6. 3.6 Global Breast Tissue Markers Company, Product Type & Application
  7. 3.7 Global Breast Tissue Markers Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Breast Tissue Markers Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Breast Tissue Markers Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Breast Tissue Markers Tier 1, Tier 2, and Tier 3
4 Breast Tissue Markers Regional Status and Outlook
  1. 4.1 Global Breast Tissue Markers Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Breast Tissue Markers Historic Market Size by Region
  3. 4.2.1 Global Breast Tissue Markers Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Breast Tissue Markers Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Breast Tissue Markers Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Breast Tissue Markers Forecasted Market Size by Region
  7. 4.3.1 Global Breast Tissue Markers Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Breast Tissue Markers Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Breast Tissue Markers Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Breast Tissue Markers by Application
  1. 5.1 Breast Tissue Markers Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Ambulatory Surgery Centers (ASCs)
  5. 5.2 Global Breast Tissue Markers Market Size by Application
  6. 5.2.1 Global Breast Tissue Markers Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Breast Tissue Markers Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Breast Tissue Markers Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Breast Tissue Markers Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Breast Tissue Markers Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Breast Tissue Markers Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Breast Tissue Markers Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Breast Tissue Markers Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Hologic
  2. 6.1.1 Hologic Company Information
  3. 6.1.2 Hologic Business Overview
  4. 6.1.3 Hologic Breast Tissue Markers Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Hologic Breast Tissue Markers Product Portfolio
  6. 6.1.5 Hologic Recent Developments
  7. 6.2 Somatex Medical
  8. 6.2.1 Somatex Medical Company Information
  9. 6.2.2 Somatex Medical Business Overview
  10. 6.2.3 Somatex Medical Breast Tissue Markers Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Somatex Medical Breast Tissue Markers Product Portfolio
  12. 6.2.5 Somatex Medical Recent Developments
  13. 6.3 Mermaid Medical
  14. 6.3.1 Mermaid Medical Company Information
  15. 6.3.2 Mermaid Medical Business Overview
  16. 6.3.3 Mermaid Medical Breast Tissue Markers Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mermaid Medical Breast Tissue Markers Product Portfolio
  18. 6.3.5 Mermaid Medical Recent Developments
  19. 6.4 Mammotome
  20. 6.4.1 Mammotome Company Information
  21. 6.4.2 Mammotome Business Overview
  22. 6.4.3 Mammotome Breast Tissue Markers Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mammotome Breast Tissue Markers Product Portfolio
  24. 6.4.5 Mammotome Recent Developments
  25. 6.5 BD
  26. 6.5.1 BD Company Information
  27. 6.5.2 BD Business Overview
  28. 6.5.3 BD Breast Tissue Markers Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 BD Breast Tissue Markers Product Portfolio
  30. 6.5.5 BD Recent Developments
  31. 6.6 Argon Medical
  32. 6.6.1 Argon Medical Company Information
  33. 6.6.2 Argon Medical Business Overview
  34. 6.6.3 Argon Medical Breast Tissue Markers Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Argon Medical Breast Tissue Markers Product Portfolio
  36. 6.6.5 Argon Medical Recent Developments
  37. 6.7 Carbon Medical Technologies
  38. 6.7.1 Carbon Medical Technologies Company Information
  39. 6.7.2 Carbon Medical Technologies Business Overview
  40. 6.7.3 Carbon Medical Technologies Breast Tissue Markers Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Carbon Medical Technologies Breast Tissue Markers Product Portfolio
  42. 6.7.5 Carbon Medical Technologies Recent Developments
  43. 6.8 INRAD
  44. 6.8.1 INRAD Company Information
  45. 6.8.2 INRAD Business Overview
  46. 6.8.3 INRAD Breast Tissue Markers Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 INRAD Breast Tissue Markers Product Portfolio
  48. 6.8.5 INRAD Recent Developments
7 North America by Country
  1. 7.1 North America Breast Tissue Markers Sales by Country
  2. 7.1.1 North America Breast Tissue Markers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Breast Tissue Markers Sales by Country (2021-2026)
  4. 7.1.3 North America Breast Tissue Markers Sales Forecast by Country (2027-2032)
  5. 7.2 North America Breast Tissue Markers Market Size by Country
  6. 7.2.1 North America Breast Tissue Markers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Breast Tissue Markers Market Size by Country (2021-2026)
  8. 7.2.3 North America Breast Tissue Markers Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Breast Tissue Markers Sales by Country
  2. 8.1.1 Europe Breast Tissue Markers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Breast Tissue Markers Sales by Country (2021-2026)
  4. 8.1.3 Europe Breast Tissue Markers Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Breast Tissue Markers Market Size by Country
  6. 8.2.1 Europe Breast Tissue Markers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Breast Tissue Markers Market Size by Country (2021-2026)
  8. 8.2.3 Europe Breast Tissue Markers Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Breast Tissue Markers Sales by Country
  2. 9.1.1 Asia-Pacific Breast Tissue Markers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Breast Tissue Markers Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Breast Tissue Markers Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Breast Tissue Markers Market Size by Country
  6. 9.2.1 Asia-Pacific Breast Tissue Markers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Breast Tissue Markers Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Breast Tissue Markers Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Breast Tissue Markers Sales by Country
  2. 10.1.1 South America Breast Tissue Markers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Breast Tissue Markers Sales by Country (2021-2026)
  4. 10.1.3 South America Breast Tissue Markers Sales Forecast by Country (2027-2032)
  5. 10.2 South America Breast Tissue Markers Market Size by Country
  6. 10.2.1 South America Breast Tissue Markers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Breast Tissue Markers Market Size by Country (2021-2026)
  8. 10.2.3 South America Breast Tissue Markers Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Breast Tissue Markers Sales by Country
  2. 11.1.1 Middle East and Africa Breast Tissue Markers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Breast Tissue Markers Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Breast Tissue Markers Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Breast Tissue Markers Market Size by Country
  6. 11.2.1 Middle East and Africa Breast Tissue Markers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Breast Tissue Markers Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Breast Tissue Markers Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Breast Tissue Markers Value Chain Analysis
  2. 12.1.1 Breast Tissue Markers Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Breast Tissue Markers Production Mode & Process
  7. 12.2 Breast Tissue Markers Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Breast Tissue Markers Distributors
  10. 12.2.3 Breast Tissue Markers Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst